I doubt this would have caused any weakness today, but there was an announcement

Chiesi partners with Haisco to commercialise bronchiectasis drug
MarketLine
20th Nov 10:15
Chiesi Group and Haisco Pharmaceutical have entered a licence agreement to jointly develop HSK31858 to treat respiratory diseases such as bronchiectasis. As part of the agreement, Haisco will receive an upfront payment, future milestone payments, and royalties on product sales. HSK31858 is a reversible dipeptidyl peptidase 1 inhibitor, currently in

Did anyone see anything about massive short covering? I believe short stick quick is mixed up when he says there was massive short covering, and it was really semi heavy shorting, unless I missed something…